FITC Anti-Human TCR γ/δ Antibody[B1]
Cat No.: FCE2956
Size：
| Product Name: | FITC Anti-Human TCR γ/δ Antibody[B1] |
| Cat No.: | FCE2956 |
| host: | Mouse |
| uniprot id: | |
| geneid: | 6964,6965 |
| application: | FCM |
| isotype: | Mouse IgG1, κ |
| form: | Liquid |
| storage: | This product can be stored at 2-8°C for 12 months. Please protected from prolonged exposure to light and do not freeze. |
| shipping: | Ice bag |
| category id: | Flow Cytometry Antibodies |
| abbreviation: | TCR γ/δ |
| conjugation: | FITC |
| species reactivity: | Human |
| usage: | Each lot of this antibody is quality control tested by flow cytometric analysis. The amount of the reagent is suggested to be used 5 µL of antibody per test (million cells in 100 µL staining volume or per 100 µL of whole blood). Please check your vial before the experiment. Since applications vary, the appropriate dilutions must be determined for individual use. |
| clone no.: | B1 |
| background: | T cell receptor (TCR) is a heterodimer consisting of an α and a β chain (TCR α/β) or a γ and a δ chain (TCR γ/δ). TCR γ/δ is involved in the recognition of certain bacterial, self-CD1 molecule, and tumor antigens bound to MHC class I. The γ/δ TCR associates with CD3 and is expressed on a subset of T cells found in the thymus, the intestinal epithelium, and the peripheral lymphoid tissues and peritoneum. Most γ/δ T cells are CD4-/CD8-, some are CD8+. T cells expressing the γ/δ TCR have been shown to play a role in oral tolerance, innate immune response for some tumor cells, and autoimmune disease. It has been reported that γ/δ T cells also play a principal role in antigen presentation. |
| target synonym: | T cell receptor γ/δ; γ/δ TCR; TCR-γ/δ; |
| concentration: | 5 μL/Test |
| buffer: | Phosphate buffered solution, pH 7.2, containing 0.09% stabilizer and 1% protein protectant. |
| image 1 description: | Human peripheral blood lymphocytes are stained with FITC Anti-Human TCR γ/δ Antibody and APC Anti-Human CD3 Antibody (Right). Lymphocytes stained with APC Anti-Human CD3 Antibody and Mouse IgG1 Isotype Control FITC (Left) are used as control. |